AI Navigate

Multimodal classification of Radiation-Induced Contrast Enhancements and tumor recurrence using deep learning

arXiv cs.CV / 3/13/2026

📰 NewsModels & Research

Key Points

  • RICE-NET is a multimodal 3D deep learning model that fuses longitudinal MRI data with radiotherapy dose distributions to automatically classify lesions as tumor recurrence or radiation-induced contrast enhancements in post-treatment glioblastoma patients.
  • In a cohort of 92 patients, the model achieved an F1 score of 0.92 on an independent test set, indicating strong performance.
  • Ablation experiments show reliable classification largely depends on the radiation map and the contributions from different timepoints and modalities, underscoring the value of multimodal data.
  • Occlusion-based interpretability analyses indicate the model focuses on clinically relevant brain regions, supporting its potential to aid diagnostic decisions in neuro-oncology.

Abstract

The differentiation between tumor recurrence and radiation-induced contrast enhancements in post-treatment glioblastoma patients remains a major clinical challenge. Existing approaches rely on clinically sparsely available diffusion MRI or do not consider radiation maps, which are gaining increasing interest in the tumor board for this differentiation. We introduce RICE-NET, a multimodal 3D deep learning model that integrates longitudinal MRI data with radiotherapy dose distributions for automated lesion classification using conventional T1-weighted MRI data. Using a cohort of 92 patients, the model achieved an F1 score of 0.92 on an independent test set. During extensive ablation experiments, we quantified the contribution of each timepoint and modality and showed that reliable classification largely depends on the radiation map. Occlusion-based interpretability analyses further confirmed the model's focus on clinically relevant regions. These findings highlight the potential of multimodal deep learning to enhance diagnostic accuracy and support clinical decision-making in neuro-oncology.